Insight Molecular Diagnostics Inc. (0KCC.L) Dividend Yield, History & Forecast

Insight Molecular Diagnostics Inc. (0KCC.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. The most recent ex-dividend date was March 15, 2022. market capitalization is approximately $103M.

Loading quote...

Frequently Asked Questions about Insight Molecular Diagnostics Inc. (0KCC.L)

When does Insight Molecular Diagnostics Inc. pay its next dividend?
The most recent ex-dividend date was March 15, 2022.
Is Insight Molecular Diagnostics Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Insight Molecular Diagnostics Inc. in?
Insight Molecular Diagnostics Inc. (0KCC.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.